Polymyositis in African HIV-infected subjects

Neuromuscular Disorders

Volumn 20, Issue 11, 2010, Pages 735-739

  Heckmann, J M ^a   Pillay, K ^b   Hearn, A P ^c   Kenyon, C ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Creatine kinase; HIV; Myopathy; Polymyositis

Indexed keywords

CREATINE KINASE; PREDNISONE;

ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ELECTROMYOGRAPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MUSCLE BIOPSY; POLYMYOSITIS; PRIORITY JOURNAL; STEROID THERAPY;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-INFLAMMATORY AGENTS; CREATINE KINASE; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; MUSCLE, SKELETAL; POLYMYOSITIS; PREDNISONE; SOUTH AFRICA; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 77957752657     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2010.06.007     Document Type: Article

References (24)

1. Illa I., Nath A., Dalakas M. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol 1991, 29(5):474-481.
2. Robinson-Papp J., Simpson D.M. Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve 2009, 40(6):1043-1053.
3. Kenyon C., Pillay K., Heckmann J.M. Beware of the " normal" creatine kinase levels in HIV-associated polymyositis: the Groote Schuur experience. S Afr Med J 2010, 100(3):156-157.
4. Bohan A., Peter J.B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292(7):344-347.
5. Chahin N., Engel A.G. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 2008, 70(6):418-424.
6. Johnson R.W., Williams F.M., Kazi S., Dimachkie M.M., Reveille J.D. Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum 2003, 49(2):172-178.
7. Statistics. South Africa National Census results 2001 [cited 2009 November 2009].
8. Pachman L.M., Hayford J.R., Chung A., et al. Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol 1998, 25(6):1198-1204.
9. Rosalki S.B. Low serum creatine kinase activity. Clin Chem 1998, 44(5):905.
10. Delanghe J.R., De Buyzere M.L. Low serum creatine kinase activity in rheumatoid arthritis. J Rheumatol 1997, 24(1):231-232.
11. Gunst J.J., Langlois M.R., Delanghe J.R., De Buyzere M.L., Leroux-Roels G.G. Serum creatine kinase activity is not a reliable marker for muscle damage in conditions associated with low extracellular glutathione concentration. Clin Chem 1998, 44(5):939-943.
12. Delanghe J., De Buyzere M., De Scheerder I., Van den Abeele A.M., Vandenbogaerde J., Wieme R. Significance of low creatine kinase in intensive-care patients. Clin Chem 1986, 32(4):713-714.
13. Black H.R., Quallich H., Gareleck C.B. Racial differences in serum creatine kinase levels. Am J Med 1986, 81(3):479-487.
14. Munier M.L., Kelleher A.D. Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. Immunol Cell Biol 2007, 85(1):6-15.
15. Swingler S., Zhou J., Swingler C., et al. Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS. Cell Host Microbe 2008, 4(1):63-76.
16. Lane H.C., Masur H., Edgar L.C., Whalen G., Rook A.H., Fauci A.S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983, 309(8):453-458.
17. Koffman B.M., Dalakas M.C. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve 1997, 20(9):1102-1107.
18. Rowland-Jones S., Dong T. Dying T-cells trigger autoimmunity in HIV. Nat Med 2007, 13(12):1413-1415.
19. Rawson P.M., Molette C., Videtta M., et al. Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection. Nat Med 2007, 13(12):1431-1439.
20. Dalakas M.C., Rakocevic G., Shatunov A., Goldfarb L., Raju R., Salajegheh M. Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T-cells. Ann Neurol 2007, 61(5):466-475.
21. van der Meulen M.F., Bronner I.M., Hoogendijk J.E., et al. Polymyositis: an overdiagnosed entity. Neurology 2003, 61(3):316-321.
22. Nozaki K., Pestronk A. High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology. J Neurol Neurosurg Psychiatry 2009, 80(8):904-908.
23. Authier F.J., Chariot P., Gherardi R.K. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). Muscle Nerve 2005, 32(3):247-260.
24. Stratton R., Slapak G., Mahungu T., Kinloch-de Loes S. Autoimmunity and HIV. Curr Opin Infect Dis 2009, 22(1):49-56.